Perspective Therapeutics(CATX) - 2025 Q4 - Annual Results

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results SEATTLE – August 13, 2025 – Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatments for cancers throughout the body, today provided a business update and announced results for the quarter ended June 30, 2025. • [ 212Pb]VMT-α-NET study update presented at the 2025 ASCO Annual Meeting, based on updated ...